AlzeCure Pharma announces change of CEO ahead of next phase of development AlzeCure Pharma announces change of CEO ahead of next phase of development AlzeCure Pharma AB (FN STO: ALZCUR), which develops small-molecule drug candidates for CNS diseases with a focus on Alzheimer’s disease and pain, announces today that CEO... Alcami Announces promotion of Robert Tragas to Vice President, Laboratory Services Alcami Announces promotion of Robert Tragas to Vice President, Laboratory Services Alcami, a leading contract development and manufacturing organisation (CDMO), today announced its strengthening of laboratory leadership with the promotion of Robert Tragas to... Touchlight announces leadership transition, with Will Downie appointed interim CEO Touchlight announces leadership transition, with Will Downie appointed interim CEO Touchlight today announces that Karen Fallen is stepping down as CEO and that the Board of Directors has appointed Will Downie as Interim Chief Executive Officer Beckman Coulter Diagnostics appoints Catherine Jennings as president Beckman Coulter Diagnostics appoints Catherine Jennings as president Former Boston Scientific executive to lead strategic and operational priorities at global diagnostics company EyeC expands OEM growth with new business development manager EyeC expands OEM growth with new business development manager Rigel Gallegos will lead the development of EyeC’s OEM and system integrator business Concept Life Sciences appoints Dr Adrijana Vinter as Chief Executive Officer Concept Life Sciences appoints Dr Adrijana Vinter as Chief Executive Officer Experienced CRO leader brings deep scientific, commercial and operational expertise to lead the company’s next phase of growth New Managing Director for Shimadzu Europa New Managing Director for Shimadzu Europa Dr. Florian Geistmann (pictured) takes over as Managing Director of Shimadzu Europa, succeeding Jürgen Semmler, who has retired after five years at the helm of the European... Three new commercial appointments for Symbiosis Three new commercial appointments for Symbiosis Symbiosis Pharmaceutical Services has expanded its commercial team with three new appointments as the specialist aseptic fill-finish CDMO targets further growth across... Lonza nominates Pearl Huang to board Lonza nominates Pearl Huang to board Lonza has nominated Pearl Huang as an independent member of its Board of Directors, bringing extensive pharmaceutical and biotechnology experience and expertise in drug... BioDuro appoints Greg Makara to lead discovery chemistry BioDuro appoints Greg Makara to lead discovery chemistry BioDuro has appointed Greg Makara, PhD, as Senior Vice President, Lead Discovery Chemistry, as the contract research, development and manufacturing organisation (CRDMO) looks... Alcami strengthens commercial operations with appointment of Will Isom Alcami strengthens commercial operations with appointment of Will Isom New appointment supports laboratory services sales and biologics growth Nuclera appoints Carl Raimond as Chief Executive Officer Nuclera appoints Carl Raimond as Chief Executive Officer Former Olink Proteomics president brings life-science tools leadership experience as Dr Michael Chen transitions to chief scientific and business officer Alcami strengthens commercial operations with appointment of Will Isom as Vice President of Laboratory Services Sales Alcami strengthens commercial operations with appointment of Will Isom as Vice President of Laboratory Services Sales Alcami, a leading contract development and manufacturing organisation (CDMO), today announced the appointment of biologics industry veteran Will Isom as Vice President of... Codis appoints Steven Facer as Chief Commercial Officer Codis appoints Steven Facer as Chief Commercial Officer Codis, a global contract development and manufacturing organisation (CDMO) specialising in spray drying, amorphous solid dispersions (ASDs), and advanced particle engineering,... Qinecsa selected as technology partner for Africa’s new continent-wide medicines safety platform Qinecsa selected as technology partner for Africa’s new continent-wide medicines safety platform Qinecsa will help deliver a continent-wide medicines safety platform connecting safety data across Africa Chiesi appoints David Khougazian as Group chief executive officer Chiesi appoints David Khougazian as Group chief executive officer David Khougazian to lead the next phase of innovation-driven growth